346 reports of this reaction
1.7% of all CEFAZOLIN SODIUM reports
#12 most reported adverse reaction
URTICARIA is the #12 most commonly reported adverse reaction for CEFAZOLIN SODIUM, manufactured by Baxter Healthcare Corporation. There are 346 FDA adverse event reports linking CEFAZOLIN SODIUM to URTICARIA. This represents approximately 1.7% of all 20,322 adverse event reports for this drug.
Patients taking CEFAZOLIN SODIUM who experience urticaria should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
URTICARIA is a less commonly reported adverse event for CEFAZOLIN SODIUM, but still significant enough to appear in the safety profile.
In addition to urticaria, the following adverse reactions have been reported for CEFAZOLIN SODIUM:
The following drugs have also been linked to urticaria in FDA adverse event reports:
URTICARIA has been reported as an adverse event in 346 FDA reports for CEFAZOLIN SODIUM. This does not prove causation, but indicates an association observed in post-market surveillance data.
URTICARIA accounts for approximately 1.7% of all adverse event reports for CEFAZOLIN SODIUM, making it a notable side effect.
If you experience urticaria while taking CEFAZOLIN SODIUM, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.